Trademarkia Logo

Canada

C$
Trademark Search in Canada
TARGINTA

View On IC.GC.CA

TARGINTA
ADVERTISED

on 1 Jan 2025

Last Applicant/ Owned by

Targinta AB

Scheelevägen 8SE-223 63 Lund

SE

Serial Number

2101486 filed on 4th Feb 2021

Correspondent Address

FURMAN IP LAW & STRATEGY PC

260-10 Research DriveOffice D/EREGINA

SASKATCHEWAN

CA

S4S7J7

TARGINTA

Trademark usage description

biological preparations for the diagnosis and treatment of oncological diseases and disorders stem cells for research and scientific purposes; antibod Read More

Classification Information

Class [001]
Biological preparations for the diagnosis and treatment of oncological diseases and disorders stem cells for research and scientific purposes; antibody reagents for scientific purposes; DNA and RNA for use in cancer diagnosis, prognosis, and treatment; proteins for use in cancer diagnosis, prognosis, and treatment; biological kits consisting of stem cells, antibodies and proteins for use in fields of biological and diagnostic testing for industrial, scientific and research use diagnostic reagents for medical scientific use; chemical analytical preparations for use in cancer treatment and cancer therapy.

Classification kind code

11

Class [005]
Pharmaceutical and veterinary preparations for the treatment of cancer and for cancer therapies; stem cells for medical purposes; stem cells for medical and veterinary use; DNA and RNA for medical and veterinary purposes, namely, gene-based RNA molucular network biomarker reagents for medical diagnosis purposes, medical therapeutic preparations in the nature of biologically active antisense DNA and RNA compounds, biological products for medical use in recombinant DNA technology in the nature of DNA products allowing recombinant production of polypeptides and monoclonal antibodies; surgical implants grown from stem cells comprising living tissues; antibodies, namely diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; biological preparations for the treatment of cancer for medical and veterinary purposes; diagnostic kit consisting of stem cells, monoclonal antibodies and proteins for use in disease testing for medical and veterinary purposes; diagnostic reagents for medical purposes; diagnostic reagents for clinical laboratory use; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; in vitro diagnostic preparations for medical purposes.

Classification kind code

11

Class [042]
Scientific research and development services in the field of products containing DNA, RNA, stem cells, antibodies and proteins for medical and veterinary use; laboratory testing services, namely, scientific research, diagnosis, testing and analysis in the fields of medicine, chemistry, stem cells, RNA, DNA, antibodies and proteins; basic and clinical research in the field of respiratory science and medicine, in particular in relation to the development of medicines; scientific research and development services in the field of diagnostic preparations containing DNA, RNA, stem cells, antibodies and proteins for medical and veterinary use; quality control services namely providing quality control for products containing DNA, RNA, stem cells, antibodies and proteins for medical and veterinary use.

Classification kind code

11

Mark Details

Serial Number

2101486

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 16th Jan 2023		Agent Changed
Submitted for opposition 22
on 4th Aug 2022		Search Recorded
Submitted for opposition 20
on 4th Aug 2022		Examiner's First Report
Submitted for opposition 223
on 4th Aug 2022		Total Provisional Refusal
Submitted for opposition 256
on 22nd Feb 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 22nd Apr 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 21st Apr 2021		Formalized
Submitted for opposition 1
on 21st Apr 2021		Created
Submitted for opposition 228
on 4th Feb 2021		International Registration
Submitted for opposition 30
on 4th Feb 2021		Filed